News & Press Release

• 20.10.26

  Sisram Medical Announces NMPA Acceptance of Profhilo Registration Application for Facial Indication

• 08.10.26

  Sisram Medical Announces Share Repurchase Plan for Up to 1% of Issued Shares

• 19.08.26

  Sisram Medical Delivers Solid 2026 Interim Results

• 05.08.26

  Sisram Medical to Announce 2026 Interim Results on Wednesday, August 19, 2026

• 05.08.26

  Sisram Medical Launches Titanium Prime Treatment Concept in Hong Kong SAR

• 04.08.26

  Sisram Medical Powers Up China EBD Growth Engine with Flagship “黑金牛奶光” Launch

• 29.06.26

  Sisram Medical’s China Manufacturing Facility Commences Operations as First Locally Produced Alma Rejuve Rolls Off the Line

• 23.06.26

  Sisram Medical Bolsters EBD and Injectables in Thailand to Unlock APAC Growth

• 28.05.26

  Sisram Medical Investor Day Key Takeaways

• 24.03.26

  Sisram Medical Reports Solid Growth in 2025